Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: INIMMUNE CORP
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-30 to 2028-09-29
Current total value of award: $5907864
Description: DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES AND EOI::EO:RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING